Docetaxel, Carboplatin, and Bevacizumab in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery

NCT00293332 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Terminated due to low subject accrual

Conditions

Lung Cancer

Interventions

BIOLOGICAL: bevacizumab
DRUG: carboplatin
DRUG: docetaxel
PROCEDURE: conventional surgery

Sponsor

University of California, San Francisco

Collaborators

[object Object]